TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: MRI measured perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: MRI measured vascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Anxious Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: subjective cognitive complaints
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Concentration of Voltage dependent anion channel 1 protein (VDAC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Microtubule-associated proteins 1B light chain 3B (LC3B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of Plasma Proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of Bacteria from the Intestinal Microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of fasting plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of 2-h plasma glucose (75 g oGTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of Safety - Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness in Reduction of Depression Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: monthly headache days with moderate to severe intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kinematic assessment of manual reach
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of postural sway during the sit-to-stand movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative changes in the relative abundance of key bacterial taxa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Evaluate Changes in Metabolic Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evaluate Changes in Inflammation Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants with local reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with systemic events
Endpoint domain: Adverse events/effects
Primary endpoint: GMCs of serotype-specific IgG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Metabolic activity in spleen measured as pyruvate-to-lactate conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: infant feeding practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healthy sleep practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant and toddler growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity-adjusted length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in step length symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in step time symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self selected gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amsterdam Preoperative Anxiety and Information Score (APAIS) survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in patient quality of life as assessed by Quality of Life (QoL) questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in (fat) volume % and soft tissue retention %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 Physical Function subscale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: sedentary level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of chromosomal instability (CIN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of brain's HbO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Relative change of postoperative Granulocyte-macrophage colony-stimulating factor (GM-CSF) plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Relative change of postoperative Interferon gamma (IFNγ) plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Relative change of postoperative Interleukin-1β plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Circulating bile acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fecal bile acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gut microbiota for metabolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Agreement rate between urine cell-free DNA and tumor tissue mutation profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pain Interference and intensity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in working memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cerebral perfusion levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of protocol adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Simplified cancer CAchexia SCOre (MiniCASCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease control rate (DCR) at 6 months after the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life measured by questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Spleen stiffness (kPa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological downstaging response <ypT2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of desaturation under 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of manual ventilation during RSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Composite of inappropriate shock and ICD related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of uptake of cascade testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety of Hi-OX sequential rebreathing device
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Primary Immunogenic indicator
Endpoint domain: Physiological/clinical
Primary endpoint: Image quality satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of days with improved bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Modified Oswestry Disability index (Disability and function)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Biological composition of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphology of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMV presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Vulvovaginal graft vs host disease presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse Event (AE) / Serious Adverse Event (SAE) Incidence Rate and Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of conversion to robotic lobectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sarcopenia Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of youth at clinical high risk for psychosis enrolled in stepped care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of youth who meet criteria for a clinical high risk for psychosis (CHRp) syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety before acupressure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety after suturing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV-seropositive partners' ART adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Evolution of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical response based on ALP and total bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of IUrisure test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of IUrisure test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMFR of neutralizing antibody to SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peripheral Cytokine: IL-1B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peripheral Cytokine: IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peripheral Cytokine: TNFα
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Brain Metabolite: N-acetyl-aspartate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain Metabolite: Choline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurocognition: Behavioral impulsivity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 6-week rebleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Validation of the Arabic version of the Western Ontario Rotator Cuff Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in peripheral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of times of Microscopic focus adjustment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total moving distance in millimeter of microscope-lens-system relative to suspension arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance of subjective focus change in millimeter between corneal surface and surface of posterior capsule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Zva Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of TLC-3595 treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Functional outcome of Ankle joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Predictive agreement between UHF-ECG and standard ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective tumor evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HF Hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Berg Balance Scale (BBS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ten Meter Walk Test (10mWT) Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six Minute Walk Test (6MWT) Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMT Anti-S IgG at 28 days after vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Suicidality subscale of the Depressive Symptom Index
Endpoint domain: Adverse events/effects
Primary endpoint: rate residual
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App use comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants with immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune infiltration characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Phenotypic characteristics of cell subgroups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functional characteristics of cell subgroups
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in percentual T-regulatory cells (Tregs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pelvic Floor Muscle Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Skalası
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Fatigue Severity Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pregnancy Weight Gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Depression Scale change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety Scale change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Experiential Avoidance change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Valuing Questionnaire-Progress change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline airway function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: SF-36 (Short form)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Knee Outcome Survey Activities of Daily Living KOS-ADLS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Late mucosal ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Performance of i-STAT hs-TnI cartridge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Instantaneous respiration rate measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Instantaneous heart rate measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knowledge after education
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: SNOT-22
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of treatment recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of therapy recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sleep Onset Latency (in minutes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Change in Sleep Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Change in Time in Bed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: General distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Usability of AI assessed by patient ratings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IOP reduction from baseline to 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total weeks worked in competitive jobs change
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Hospital referral rate for acute chest pain
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Diagnostic accuracy of the clinical decision rule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of WSD0628
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase 2 dose of WSD0628
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 95th CPAP unintentional leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical phenotype characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Cure of Clinical Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma concentration-time curve from time 0 to the last quantifiable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of perceived understanding of information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Free Survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: procedure or device related mortality
Endpoint domain: Mortality/survival
Primary endpoint: rate of re-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: acceptable hemodynamic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: proportion of patients with chronic postsurgical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of pre treatment antibiotic culture and sensitivity test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Detection of vacuolating cytotoxin A and cytotoxin-associated gene A virulent Helicobacter Pylori genotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Relation of histopathological examination (gastritis classification) to clinical presentation and to resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CGM-derived time in range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Establish the maximum tolerated dose (MTD) as determined by occurrence of DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: extinction learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung cancer screening uptake rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Seroprevalence of CMV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Seroincidence of primary CMV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Positive Mental Health Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen Free Days Through Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of haemorrhoid symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of haemorrhoid symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shrinkage of haemorrhoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first onset of cardiorenal composite outcome event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of articaine administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: HP 13C bicarbonate-to-lactate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in 24 hour urinary oxalate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in 24 hour urinary calcium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pharmacokinetic (PK) levels in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in the scar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Effectiveness of vision processing method in the laboratory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of vision processing method in the 'real world' featured environment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity exercise capacity assessed by 1 minute sit to stand test (STS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper lower extremity exercise capacity assessed by 6 minutes pegboard and ring test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea assessed by mMRC dyspnea scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of molecular markers of antimalarial resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes